B of A Securities Maintains Buy on Cellebrite DI, Raises Price Target to $25
Benzinga Newsdesk 12 months ago
NewsPrice TargetAnalyst Ratings
B of A Securities analyst Tal Liani maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $24 to $25.
B of A Securities analyst Tal Liani maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $24 to $25.